Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Prime Medicine Inc’s stock clocked out at $1.33, up 13.68% from its previous closing price of $1.17. In other words, the price has increased by $13.68 from its previous closing price. On the day, 1.74 million shares were traded. PRME stock price reached its highest trading level at $1.33 during the session, while it also had its lowest trading level at $1.16.
Ratios:
To gain a deeper understanding of PRME’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.58 and its Current Ratio is at 5.58. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.24.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on December 10, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $10.
On May 20, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
Citigroup Upgraded its Neutral to Buy on May 16, 2024, while the target price for the stock was maintained at $10.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRME now has a Market Capitalization of 174444128 and an Enterprise Value of 20144280. For the stock, the TTM Price-to-Sale (P/S) ratio is 58.54 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 6.753 whereas that against EBITDA is -0.103.
Stock Price History:
The Beta on a monthly basis for PRME is 2.20, which has changed by -0.75551474 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, PRME has reached a high of $8.27, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -38.89%, while the 200-Day Moving Average is calculated to be -62.13%.
Shares Statistics:
It appears that PRME traded 1.28M shares on average per day over the past three months and 2049000 shares per day over the past ten days. A total of 131.16M shares are outstanding, with a floating share count of 51.92M. Insiders hold about 60.42% of the company’s shares, while institutions hold 31.22% stake in the company. Shares short for PRME as of 1743379200 were 18302982 with a Short Ratio of 14.31, compared to 1740700800 on 18042942. Therefore, it implies a Short% of Shares Outstanding of 18302982 and a Short% of Float of 26.810000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
